Department of Health

Receiving Officer 04:27 PM, Aug 19, 2022

August 19, 2022

Dear Jordan,

Thank you for your request dated Aug 19, 2022 under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for The Top Most Counterfeited Over the Counter Medications in the Philippines.

We received your request on Aug 19, 2022 and will respond on or before Sep 09, 2022 04:05:44 PM, in accordance with the Executive Order's implementing rules and regulations.

Should you have any questions regarding your request, kindly contact me using the reply function on the eFOI portal at https://pcoomaster03162018130000-dot-efoi-ph.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC01MTA1NTM2MjUyMzAM, for request with ticket number #DOH-510553625230.

Thank you.

Respectfully,

FOI Receiving Officer
FOI Officer

Maker 04:55 PM, Aug 19, 2022

Dear  Jordan H

Please  be advised that your request has been endorsed to FDA for action. Kindly await for their response, thank you

Maker 08:34 PM, Sep 09, 2022

September 9, 2022

Dear Jordan H,

Greetings!

Thank you for your request dated Aug 19, 2022 04:05:44 PM under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch.

Your Request

You asked for The Top Most Counterfeited Over the Counter Medications in the Philippines.

Response to Request

Your FOI request is approved.

Below is the List of top 10 counterfeited drug products. The image of which can be seen in the issued advisories posted on the FDA website (https://www.fda.gov.ph/).

Top 10 Counterfeit Drug Products (2020-2022) as of August 2022

1. Product/Brand: Biogesic
No. of Counterfeit Drug Product: 52
FDA Advisory Issued
2020-1348, 2021-2263, 2022-0135, 2022-0272, 2022-0273,
2022-0277, 2022-0413, 2022-0477, 2022-0478, 2022-0479,
2022-0480, 2022-0481, 2022-0484, 2022-0621, 2022-0779,
2022-0780, 2022-0783, 2022-0785, 2022-1004

2. Product/Brand: Neozep Forte 
No. of Counterfeit Drug Product: 46
FDA Advisory Issued
2020-1348, 2020-1877, 2021-2208, 2021-2291, 2021-2263,
2022-0272, 2022-0273, 2022-0277, 2022-0413, 2022-0477,
2022-0479, 2022-0611, 2022-0619, 2022-0679, 2022-0780,
2022-1014

3. Product/Brand: Alaxan FR
No. of Counterfeit Drug Product: 35
FDA Advisory Issued
2020-1348, 2021-2263, 2021-3535, 2022-0277, 2022-0477,
2022-0545, 2022-0611, 2022-0618, 2022-0620, 2022-0676,
2022-0678, 2022-0784, 2022-0939, 2022-1014, 2022-1036,
2022-1081

4. Product/Brand: Bioflu
No. of Counterfeit Drug Product: 34
FDA Advisory Issued
2020-1348, 2021-3535, 2022-0134, 2022-0270, 2022-0272,
2022-0273, 2022-0277, 2022-0280, 2022-0413, 2022-0479,
2022-0611, 2022-0621, 2022-0677, 2022-0678, 2022-0779,
2022-0784, 2022-0939, 2022-1081

5. Product/Brand: Tuseran Forte
No. of Counterfeit Drug Product: 23
FDA Advisory Issued
2020-1348, 2020-190, 2022-0478, 2022-0479, 2022-0480,
2022-0611, 2022-0617, 2022-0618, 2022-0677, 2022-0679,
2022-1014, 2022-1081

6. Product/Brand: Diatabs
No. of Counterfeit Drug Product: 22
FDA Advisory Issued
2020-1348, 2020-1877, 2021-2292, 2021-2263, 2022-0438,
2022-0478, 2022-0479, 2022-0483, 2022-0611, 2022-0644,
2022-0677, 2022-1081

7. Product/Brand: Solmux
No. of Counterfeit Drug Product: 19
FDA Advisory Issued
2020-1348, 2020-1877, 2021-3535, 2022-0273, 2022-0477,
2022-0478, 2022-0541, 2022-0617, 2022-0645, 2022-0677,
2022-0781, 2022-0782, 2022-1089

8. Product/Brand: Flanax Forte
No. of Counterfeit Drug Product: 18
FDA Advisory Issued
2022-0478, 2022-0479, 2022-0484, 2022-0611, 2022-0645,
2022-0939, 2022-0941

9.  Product/Brand: Decolgen Forte
No. of Counterfeit Drug Product: 17
FDA Advisory Issued
2022-0277, 2022-0413, 2022-0611, 2022-0676, 2022-0678,
2022-1081

10. Product/Brand: Medicol Advance
No. of Counterfeit Drug Product: 15
FDA Advisory Issued
2022-0277, 2022-0479, 2022-0484, 2022-0611, 2022-0678,
2022-094

Kindly accomplish the FOI Request Feedback form at the link:
https://bit.ly/DOHFOIFeedbackForm

Thank you

Your right to request a review

If you are unhappy with this response to your FOI request, you may ask us to carry out an internal review of the response by writing to the DOH Central Appeals and Review Committee, at foi@doh.gov.ph. Your review request should explain why you are dissatisfied with this response, and should be made within 15 calendar days from the date when you received this letter. We will complete the review and tell you the result within 30 calendar days from the date when we receive your review request.

If you are not satisfied with the result of the review, you then have the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011).

Thank you.

Respectfully,

FOI Decision Maker
FOI Receiving Officer

Maker 10:00 PM, Jan 30, 2024

January 30, 2024

Dear Jordan H,

I refer to my letter of Aug 19, 2022 04:05:44 PM about your request under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for The Top Most Counterfeited Over the Counter Medications in the Philippines.

In order for us to work further on your request, we need more information from you regarding your query. We apologize for the delay of response. May we know if you still need this information? Kindly email us at foi@doh.gov.ph

You may use the reply function on the eFOI portal at https://foipmo04282020102259-dot-efoi-ph.uc.r.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC01MTA1NTM2MjUyMzAM, for request with ticket number #DOH-510553625230, to respond.

During the period of us awaiting your reply, your request will be put on hold. If we do not receive a reply on or before Apr 23, 2024 01:59:55 PM, your request will be closed.

We hope to hear from you at the soonest possible time.

Thank you.

Respectfully,

FOI Decision Maker
FOI Officer